Exact Mass: 353.2330976

Exact Mass Matches: 353.2330976

Found 71 metabolites which its exact mass value is equals to given mass value 353.2330976, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Levomethadyl Acetate

(1S,4S)-4-(Dimethylamino)-1-ethyl-2,2-diphenylpentyl acetic acid

C23H31NO2 (353.2354666)


Levomethadyl Acetate is only found in individuals that have used or taken this drug. It is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]Opiate receptors (Mu, Kappa, Delta) are coupled with G-protein receptors and function as both positive and negative regulators of synaptic transmission via G-proteins that activate effector proteins. Binding of the opiate stimulates the exchange of GTP for GDP on the G-protein complex. As the effector system is adenylate cyclase and cAMP located at the inner surface of the plasma membrane, opioids decrease intracellular cAMP by inhibiting adenylate cyclase. Subsequently, the release of nociceptive neurotransmitters such as substance P, GABA, dopamine, acetylcholine and noradrenaline is inhibited. Opioids also inhibit the release of vasopressin, somatostatin, insulin and glucagon. Levomethadyl acetate effectively opens calcium-dependent inwardly rectifying potassium channels (OP1 receptor agonist), resulting in hyperpolarization and reduced neuronal excitability. N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Methadyl Acetate

(3R,6R)-3-Acetoxy-6-dimethylamino-4,4-diphenylheptane

C23H31NO2 (353.2354666)


Methadyl Acetate is only found in individuals that have used or taken this drug. It is a narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence. [PubChem]Methadyl Acetate is primarily a mu-type opioid receptor agonist. It functions similarily to methadone. D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-

Butanoic acid, 3-((2-((3R)-2-oxo-3-(2-(4-piperidinyl)ethyl)-1-piperidinyl)acetyl)amino)-, (3R)-

C18H31N3O4 (353.23144460000003)


   

Proadifen

2-(Diethylamino)ethyl 2,2-diphenylpentanoic acid

C23H31NO2 (353.2354666)


   

proadifen

proadifen

C23H31NO2 (353.2354666)


C471 - Enzyme Inhibitor > C29574 - Nitric Oxide Synthase Inhibitor D004791 - Enzyme Inhibitors

   

1-[1]Naphthyl-cyclohexancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclohexanecarboxylic acid-(2-diethylamino-ethyl ester)

1-[1]Naphthyl-cyclohexancarbonsaeure-(2-diaethylamino-aethylester)|1-[1]naphthyl-cyclohexanecarboxylic acid-(2-diethylamino-ethyl ester)

C23H31NO2 (353.2354666)


   

suaveolindole

suaveolindole

C23H31NO2 (353.2354666)


A terpenoid indole alkaloid that is 1H-indole substituted by cyclohexylmethyl ring at position 3 which in turn is substituted by additional methyl groups at positions 2 and 3, a propan-2-ylidene group at position 6 and a 2-carboxyethyl group at position 1. Isolated from Greenwayodendron suaveolens, it exhibits antibacterial activity.

   
   

(8,9-dihydroxy)-3-farnesylindole

(8,9-dihydroxy)-3-farnesylindole

C23H31NO2 (353.2354666)


   

1-methyl-2-[9?-oxo-(E)-7?-tridecenyl]-4(1H)-quinolone|euocarpine C

1-methyl-2-[9?-oxo-(E)-7?-tridecenyl]-4(1H)-quinolone|euocarpine C

C23H31NO2 (353.2354666)


   

1-methyl-2-[8?-oxo-(E)-9?-tridecenyl]-4(1H)-quinolone|euocarpine D

1-methyl-2-[8?-oxo-(E)-9?-tridecenyl]-4(1H)-quinolone|euocarpine D

C23H31NO2 (353.2354666)


   
   

1-methyl-2-[7-carbonyl-(E)-9-tridecenyl]-4(1H)-quinolone

1-methyl-2-[7-carbonyl-(E)-9-tridecenyl]-4(1H)-quinolone

C23H31NO2 (353.2354666)


   

(8α,9β-Dihydroxy)-3-farnesylindole

(8α,9β-Dihydroxy)-3-farnesylindole

C23H31NO2 (353.2354666)


   

Methadyl acetate

Acetilmetadol [inn-spanish];Acetylmethadol;Acetylmethadolum [inn-latin];Betamethadol

C23H31NO2 (353.2354666)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

SPBP 16:0;O2

Hexadecaphinganine-1-phosphate

C16H36NO5P (353.2330976)


   

Motretinide

2,4,6,8-Nonatetraenamide,N-ethyl-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (2E,4E,6E,8E)-

C23H31NO2 (353.2354666)


D - Dermatologicals > D10 - Anti-acne preparations > D10A - Anti-acne preparations for topical use > D10AD - Retinoids for topical use in acne C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C804 - Retinoic Acid Agent C308 - Immunotherapeutic Agent > C129820 - Antineoplastic Immunomodulating Agent D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids

   

3-(2-methoxy-5-methylphenyl)-3-phenyl-N,N-di(propan-2-yl)propanamide

3-(2-methoxy-5-methylphenyl)-3-phenyl-N,N-di(propan-2-yl)propanamide

C23H31NO2 (353.2354666)


   

1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol

1-[1-(4-Benzyloxyphenyl)-2-(dimethylamino)ethyl]cyclohexanol

C23H31NO2 (353.2354666)


   

Betacetylmethadol

[(3S,6R)-6-(dimethylamino)-4,4-diphenylheptan-3-yl] acetate

C23H31NO2 (353.2354666)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   

Alphacetylmethadol

(3R,6R)-6-(Dimethylamino)-4,4-diphenyl-3-heptanyl acetate

C23H31NO2 (353.2354666)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics

   

Enzaprost F

Enzaprost F

C20H33O5- (353.23278680000004)


D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics

   

prostaglandin E1(1-)

prostaglandin E1(1-)

C20H33O5- (353.23278680000004)


Conjugate base of prostaglandin E1.

   

(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

(5Z,9E,14Z)-(8xi,11xi,12S)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

C20H33O5- (353.23278680000004)


   

11-epi-prostaglandin F2alpha(1-)

11-epi-prostaglandin F2alpha(1-)

C20H33O5- (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of 11-epi-prostaglandin F2alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin H1(1-)

prostaglandin H1(1-)

C20H33O5- (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin H1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

prostaglandin D1(1-)

prostaglandin D1(1-)

C20H33O5- (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin D1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,9E,12S,14Z)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

(5Z,9E,12S,14Z)-8,11,12-Trihydroxyicosa-5,9,14-trienoate

C20H33O5- (353.23278680000004)


Conjugate base of (5Z,9E,12S,14Z)-8,11,12-trihydroxyicosa-5,9,14-trienoic acid arising from deprotonation of the carboxylic acid function.

   

trioxilin A3(1-)

trioxilin A3(1-)

C20H33O5- (353.23278680000004)


The trioxilin anion that is the anion formed from trioxilin A3 by deprotonation of its carboxylic acid moiety; major microspecies present at pH 7.3.

   

trioxilin B3(1-)

trioxilin B3(1-)

C20H33O5- (353.23278680000004)


The trioxilin anion that is the anion formed from trioxilin B3 by deprotonation of its carboxylic acid moiety; major microspecies present at pH 7.3.

   

13,14-dihydrolipoxin A4(1-)

13,14-dihydrolipoxin A4(1-)

C20H33O5- (353.23278680000004)


A hydroxy fatty acid anion obtained by deprotonation of the carboxy function of 13,14-dihydrolipoxin A4; major species at pH 7.3.

   

15-ketoprostaglandin F1alpha(1-)

15-ketoprostaglandin F1alpha(1-)

C20H33O5- (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of 15-ketoprostaglandin F1alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oate

(5Z,9alpha,11alpha)-9,11-dihydroxy-15-oxoprost-5-en-1-oate

C20H33O5- (353.23278680000004)


   

11alpha-Hydroxy-9,15-dioxoprostan-1-oate

11alpha-Hydroxy-9,15-dioxoprostan-1-oate

C20H33O5- (353.23278680000004)


   

(8S,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C17H31N5O3 (353.2426776)


   

prostaglandin F2beta(1-)

prostaglandin F2beta(1-)

C20H33O5- (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin F2beta, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N-cyclohexyl-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

(8R,9R)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

(8R,9R)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9R)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C17H31N5O3 (353.2426776)


   

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

(8S,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8S,9R)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C17H31N5O3 (353.2426776)


   

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C17H31N5O3 (353.2426776)


   

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

(8R,9S)-9-[(dimethylamino)methyl]-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-5-one

C17H31N5O3 (353.2426776)


   

(8S,9S)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

(8S,9S)-9-[(dimethylamino)methyl]-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-5-one

C17H31N5O3 (353.2426776)


   

N-cyclohexyl-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

N-cyclohexyl-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

N-cyclohexyl-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

N-cyclohexyl-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

N-cyclohexyl-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

N-cyclohexyl-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

N-cyclohexyl-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

N-cyclohexyl-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[[oxo(propylamino)methyl]amino]-3,6-dihydro-2H-pyran-6-yl]acetamide

C18H31N3O4 (353.23144460000003)


   

8-epi-prostaglandin F2alpha(1-)

8-epi-prostaglandin F2alpha(1-)

C20H33O5- (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of 8-epi-prostaglandin F2alpha, obtained by deprotonation of the carboxy group. Major structure at pH 7.3.

   

(5Z,8Z,12E)-11,14,15-Trihydroxyicosa-5,8,12-trienoate

(5Z,8Z,12E)-11,14,15-Trihydroxyicosa-5,8,12-trienoate

C20H33O5- (353.23278680000004)


   

11,12,15-trihydroxyeicosa-(5Z,8Z,13E)-trienoate

11,12,15-trihydroxyeicosa-(5Z,8Z,13E)-trienoate

C20H33O5- (353.23278680000004)


   

13,14,15-trihydroxyeicosa-(5Z,8Z,11Z)-trienoate

13,14,15-trihydroxyeicosa-(5Z,8Z,11Z)-trienoate

C20H33O5- (353.23278680000004)


   

Monascaminone methyl ether

Monascaminone methyl ether

C23H31NO2 (353.2354666)


   

Levacetylmethadol

Levomethadyl Acetate

C23H31NO2 (353.2354666)


N - Nervous system > N07 - Other nervous system drugs > N07B - Drugs used in addictive disorders > N07BC - Drugs used in opioid dependence D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

prostaglandin F2alpha(1-)

prostaglandin F2alpha(1-)

C20H33O5 (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of prostaglandin F2alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

13,14-dihydro-15-oxoprostaglandin E1(1-)

13,14-dihydro-15-oxoprostaglandin E1(1-)

C20H33O5 (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of 13,14-dihydro-15-oxoprostaglandin E1, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

C16 Sphinganine-1-phosphate

C16 Sphinganine-1-phosphate

C16H36NO5P (353.2330976)


   

11,12,15-trihydroxy-(5Z,8Z,13E)-icosatrienoate

11,12,15-trihydroxy-(5Z,8Z,13E)-icosatrienoate

C20H33O5 (353.23278680000004)


A trihydroxyicosatrienoate that is the conjugate base of 11,12,15-trihydroxy-(5Z,8Z,13E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

11,14,15-trihydroxy-(5Z,8Z,12E)-icosatrienoate(1-)

11,14,15-trihydroxy-(5Z,8Z,12E)-icosatrienoate(1-)

C20H33O5 (353.23278680000004)


A trihydroxyicosatrienoate that is the conjugate base of 11,14,15-trihydroxy-(5Z,8Z,12E)-icosatrienoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

13,14-dihydro-15-keto-PGF2alpha(1-)

13,14-dihydro-15-keto-PGF2alpha(1-)

C20H33O5 (353.23278680000004)


A prostaglandin carboxylic acid anion that is the conjugate base of 13,14-dihydro-15-keto-PGF2alpha, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

C16 Sphinganine 1-phosphate

C16 Sphinganine 1-phosphate

C16H36NO5P (353.2330976)


   

12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

12-(1h-indol-3-yl)-2,6,10-trimethyldodeca-2,6,10-triene-4,5-diol

C23H31NO2 (353.2354666)